GM2 ganglioside — Drug Target
All drugs that target GM2 ganglioside — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Phase 3 pipeline (1)
- GM2-KLH vaccine · European Organisation for Research and Treatment of Cancer - EORTC · Cancer vaccine · Oncology
GM2-KLH vaccine stimulates the immune system to recognize and attack cancer cells expressing the GM2 ganglioside antigen on their surface.